1Smith SK. Regulation of angiogenesis in the endometrium [ J ]. Trends Endocrinol Metab,2001,12(4) : 147-151.
2Ota H, Tanaka T. Stromal vascularization in the endometriosis during adenomyosis [ J ]. Microsc Res Tech, 2003,60(4) : 445-449.
3Carmeliet P, Collen D. Molecular analysis of blood vessel fomation and disease[ J]. Am J Physiol, 1997,237 (5 Pt 2) : H2091-2104.
4Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors inendometriosis[J] .Ann N Y Acad Sci,2002,955:89-100.
5Taylor RN, Lebovic DI, Hornung D, et al. Endocrine and paracrine regulation of endometrial angiogenesis[ J]. Ann N Y Acad Sci,2001,943:109-121.
6Barcz E, Rozewska ES, Kaminski P, et al. Angiogenic activity and IL-8 concentrations in peritoneal fluid and sera in endometriosis [ J ]. Int J Gynaecol Obstet, 2002,79(3) : 229-235.
9Gasparini G, Longo R, Fanelli M, et al. Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions [ J ]. J Clin Oncol, 2005.23 (6), 1295 - 1311.
10Fraser HM, Lurn SF. Angiogenesis and its control in the female reproductive system[J] .Br Med Bull,2000,56(3):789-797.
二级参考文献17
1[1]Stephen BF, Peter KM, Diokno PC, et al. Angiogenesis and its relation with tumor pathology[J] .J Pathol,1996,179:232-234.
2[2]Mazure N, Chen E, Yeh P, et al. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression[J] .Cancer Res,1996,119(3):333-339.
3[3]Wagatsuma S, Lonno R, Sato S, et al. Tumor angiogenesis,hepatocyte growth factor, and c-Met expression in endometrial carcinoma[J].Cancer, 1998,ADS-82(3):520-530.
4[4]Volpert OV, Dameron KM, Bouck N. Sequential developent of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity[J].Oncogene,1997,14:1495-1502.
5[5]Giri D, Ittmann M. Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma[J].Hum Pathol,1999,30(4):419-424.
6[6]Giatromanolaki A, Siviridis E, Koukourakis MI, et al. Introtumoral angiogenesis: a new prognostic indecator for stage I endometrial adenocarcinomas[J]? Oncol Res,1999,Ads-11(4):205-212.
7[7]Guidi AJ, Abu jiawdeh, Tognazzi K, et al. Expression of vascular permeability factor(vascular endothelial growrh factor) and its receptors in endothelial carcinomar[J].Eur J Cancer,2000,36(1):68-73.
8[8]Miyagi Y, Yoshinouchi M, Kudo T. Vascular endothelial growth factor and platelet-derived endotheial cell growth factor expression are implicated in the angiogenesis of endometrial cancer[J].Eur Jcancer,2000,36(1):68-73.
9[9]Siviridis E, Giatromanolaki A, Koulourakis MI, et al. Thymidine phosphorylase expression in endometrial carcinomas[J].Clin Exp metastasis,1999,17(5):445-450.
10[10]Fujimoto J, Hori M, Ichigo S, et al. Expression of the fibroblast growth factor family(FGF-1,-2 and -4)inendometrial cancer[J].Eur J Gynaecol Incol,1997,28(2):215-219.
2Harada T,Iwabe T,Terakawa N.Role of cytokines in endometriosis[J].Fertil Steril,2001,76(1):1-10.
3Jones RC.The effect of a luteinizing hormone releasing hormone (LRH)agonist (Wy-40,972)levohorgestrel,danazol and ovariectomy on experimental endometriosis in the rat[J].Acta Endarinol,1984,106(2):282-288.
